Onconova Therapeutics Announces the Initiation of a Phase 1/2a Study of Rigosertib plus Nivolumab for the Treatment of KRAS+ Lung Adenocarcinoma
June 22, 2020 08:00 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., June 22, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Gentherm Names Jennifer Zoldos as Chief Accounting Officer
June 22, 2020 08:00 ET
|
Gentherm Inc.
NORTHVILLE, Mich., June 22, 2020 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader and developer of innovative thermal management technologies, today announced that Jennifer Zoldos...
Price Transparency and Self-Service Options Can Benefit Healthcare Providers as Patients Return for Care
June 22, 2020 08:00 ET
|
TransUnion
Combined technologies of TransUnion Healthcare and VisitPay create a differentiated patient financial experience, addressing need for transparency and personalization CHICAGO, June 22, 2020 (GLOBE...
Ziopharm Oncology Completes Enrollment of Phase 2 Trial Evaluating Controlled IL-12 in Combination with Libtayo® in Patients with Glioblastoma
June 22, 2020 08:00 ET
|
ZIOPHARM Oncology Inc
BOSTON, June 22, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or “the Company”) (Nasdaq:ZIOP) today announced that 36 subjects have been enrolled in the phase 2 clinical trial...
Sysco Donates 30 Million Meals, ‘Making Every Case Count’ in a Global Effort to Support Vulnerable, Food-Insecure Citizens
June 22, 2020 08:00 ET
|
Sysco Corporation
HOUSTON, June 22, 2020 (GLOBE NEWSWIRE) -- Today, Sysco announced it has donated 30 million meals across eight countries since mid-March as part of its community response strategy to the COVID-19...
Sarepta Therapeutics and Codiak BioSciences Collaborate to Research and Develop Exosome-Based Therapeutics for Rare Diseases
June 22, 2020 08:00 ET
|
Sarepta Therapeutics, Inc.
- Alliance to explore the utility of engineered exosomes developed with Codiak’s engEx™ Platform to deliver gene therapy, gene editing and RNA technologies - - Two-year, global research and option...
MyoKardia Announces Positive Data from Phase 2a Clinical Trial of Danicamtiv Presented at ESC’s HFA Discoveries with Simultaneous Publication in European Journal of Heart Failure
June 22, 2020 08:00 ET
|
MyoKardia, Inc.
Danicamtiv was Well Tolerated; Demonstrated Improvements in Cardiac Contractility and Preserved Diastolic Function in Patients with Stable Heart Failure with Reduced Ejection Fraction New...
Immutep receives A$1,437,826 R&D Tax Incentive
June 22, 2020 08:00 ET
|
Immutep Limited
SYDNEY, Australia, June 22, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”), is pleased to announce that it has received a A$1,437,826 cash rebate from...
Mateon and GMP Completed Research and Service Agreement
June 22, 2020 08:00 ET
|
Mateon Therapeutics
AGOURA HILLS, Calif., June 22, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (“Mateon” or the “Company”) (OTCQB:MATN) announces that both Golden Mountain Partners (GMP) and Mateon have...
Rusken Packaging Selects PowerFleet® For Optimized Trailer Efficiency
June 22, 2020 08:00 ET
|
PowerFleet, Inc.
WOODCLIFF LAKE, N.J., June 22, 2020 (GLOBE NEWSWIRE) -- PowerFleet, Inc. (Nasdaq: PWFL), a global leader and provider of subscription-based wireless IoT and M2M solutions for securing, controlling,...
- September 28, 2024 22:48 ET Journalists from 14 Countries Conclude Tour of China’s Ningxia Hui Autonomous Region
- September 28, 2024 10:00 ET Argy Bargy Completes IDO, Setting up its Revolutionary Match3 Collection Card RPG in the Web3 Gaming Space